EDNRA and systemic sclerosis: Potential pathogenic effects of anti-AT1R and anti-ETAR antibodies were also tested in vivo by the passive transfer of anti-AT1R and anti-ETAR positive IgG fractions of SSc patients into healthy C57BL6/6J mice [68,86].